Reduce Incidence of Pre-Dialysis Hyperkalaemia With Sodium Zirconium Cyclosilicate in Chinese Subjects
Status:
Recruiting
Trial end date:
2021-12-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of Sodium Zirconium
Cyclosilicate (SZC), as well as the appropriateness of the dosing mechanism, in Chinese
end-stage renal disease (ESRD) patients on chronic haemodialysis.